Drug Trial Radar · NCT01155310
Efficacy of Helium/Oxygen Compared to Air/Oxygen in Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)
Last checked: Nov 19, 2026Latest source record: Oct 7, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
446
Actual
Start
May 2010
Primary completion
Oct 2013
Study completion Jun 2014
Sponsor
- Lead sponsor
- Air Liquide Santé InternationalIndustry
- Sponsor type
- Industry
- First posted
- Jul 1, 2010
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 35 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of the study is to evaluate the efficacy of Helium/Oxygen (He/O2) 78%/22% compared to a conventional Air/O2 mixture in reducing endotracheal intubation rate and mortality in patients with severe hypercapnic exacerbations of Chronic Obstructive Pulmonary Disease (COPD) during their index Intensive/Intermediate Care Unit (ICU) stay.
Conditions
- Chronic Obstructive Pulmonary Disease
Interventions
Helium/Oxygen 78%/22%Drug
The Helium/Oxygen mixture will be administered during NIV and NIV-free sessions for a maximum of 72 hours using study dedicated devices. Patients will then receive the Air/Oxygen mixture with usual devices.
Air/OxygenDrug
The Helium/Oxygen mixture will be administered during NIV and NIV-free sessions for a maximum of 72 hours using study dedicated devices. Patients will then receive the Air/Oxygen mixture with usual devices.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Reduction of NIV failureTime frame: 10 days (average)
Locations
16 sites in 6 countries. Site status is shown where the registry gives one.
Cliniques Universitaires Saint Luc
Brussels, Belgium
Les Cliniques Universitaires UCL Mont Godinne
Yvoir, Belgium
Centre Hospitalier Universitaire Angers
Angers, France
Centre Hospitalier Universitaire Pellegrin-Tripode
Bordeaux, France
Hôpitaux de Chartes
Chartres, France
CHU Clermont-Ferrand - Hôpital ESTAING
Clermont-Ferrand, France
Hôpital Henri Mondor
Créteil, France
CHU NICE - Hopital Pasteur
Nice, France
Hôpital Cochin
Paris, France
Hôpital Européen Georges Pompidou
Paris, France
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer - Hopital Sainte Musse
Toulon, France
Azienda Ospedaliera Univeritaria Careggi
Florence, Italy
Hôpitaux Universitaires de Genève
Geneva, Switzerland
Hôpital Abderrahmen Mami
Aryanah, Tunisia
Centre Hospitalier Universitaire Fattouma Bourguiba
Monastir, Tunisia
University Hospital of North Tees
Stockton-on-Tees, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.